Equities research analysts expect that U.S. Physical Therapy, Inc. (NYSE:USPH) will post sales of $106.49 million for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for U.S. Physical Therapy’s earnings. The highest sales estimate is $110.91 million and the lowest is $102.07 million. U.S. Physical Therapy posted sales of $90.86 million in the same quarter last year, which would indicate a positive year over year growth rate of 17.2%. The firm is scheduled to announce its next earnings report before the market opens on Thursday, March 8th.

According to Zacks, analysts expect that U.S. Physical Therapy will report full-year sales of $106.49 million for the current financial year, with estimates ranging from $406.92 million to $415.75 million. For the next financial year, analysts forecast that the firm will report sales of $451.17 million per share, with estimates ranging from $440.26 million to $462.09 million. Zacks’ sales averages are a mean average based on a survey of research analysts that cover U.S. Physical Therapy.

Several research analysts have commented on the company. Cantor Fitzgerald reissued a “buy” rating and set a $80.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, January 9th. BidaskClub raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, October 25th. Zacks Investment Research raised U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $82.00 target price for the company in a research note on Saturday, January 6th. Finally, Barrington Research downgraded U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a research note on Friday, November 3rd. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. U.S. Physical Therapy has a consensus rating of “Buy” and a consensus price target of $73.80.

U.S. Physical Therapy (NYSE USPH) traded down $0.60 during mid-day trading on Friday, reaching $72.30. The company had a trading volume of 56,572 shares, compared to its average volume of 46,466. The firm has a market capitalization of $927.86, a P/E ratio of 35.63, a PEG ratio of 2.72 and a beta of 1.22. U.S. Physical Therapy has a fifty-two week low of $56.50 and a fifty-two week high of $78.00. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.04 and a current ratio of 2.04.

In other news, CFO Lawrance W. Mcafee sold 2,000 shares of the business’s stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $68.68, for a total transaction of $137,360.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Mark J. Brookner sold 2,625 shares of the business’s stock in a transaction dated Wednesday, December 27th. The stock was sold at an average price of $71.23, for a total value of $186,978.75. The disclosure for this sale can be found here. In the last three months, insiders have sold 10,875 shares of company stock valued at $775,331. Insiders own 3.10% of the company’s stock.

Several large investors have recently added to or reduced their stakes in USPH. Copeland Capital Management LLC bought a new stake in shares of U.S. Physical Therapy during the fourth quarter worth about $12,459,000. BlackRock Inc. grew its holdings in shares of U.S. Physical Therapy by 2.5% during the fourth quarter. BlackRock Inc. now owns 1,621,087 shares of the company’s stock worth $117,043,000 after purchasing an additional 40,093 shares during the last quarter. Wells Fargo & Company MN grew its holdings in shares of U.S. Physical Therapy by 62.1% during the third quarter. Wells Fargo & Company MN now owns 73,542 shares of the company’s stock worth $4,519,000 after purchasing an additional 28,170 shares during the last quarter. OxFORD Asset Management LLP grew its holdings in shares of U.S. Physical Therapy by 491.6% during the third quarter. OxFORD Asset Management LLP now owns 33,231 shares of the company’s stock worth $2,041,000 after purchasing an additional 27,614 shares during the last quarter. Finally, King Luther Capital Management Corp grew its holdings in shares of U.S. Physical Therapy by 61.3% during the third quarter. King Luther Capital Management Corp now owns 57,695 shares of the company’s stock worth $3,545,000 after purchasing an additional 21,935 shares during the last quarter. Institutional investors own 95.97% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://theolympiareport.com/2018/02/13/106-49-million-in-sales-expected-for-u-s-physical-therapy-inc-usph-this-quarter.html.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.